Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country
Choose language: English

Potentially true Overinterpreted Certainty of evidence: low provisional C-ORG-10

Hysterectomy (even with ovaries conserved) harms the heart and metabolism; uterus and ovaries form a hormonal network protecting heart, brain and bone.

In short: Partly supported: hysterectomy is associated with a modest increase in cardiovascular disease, mainly stroke and in younger women, but not with higher mortality, and the claimed protective 'hormonal network' of the uterus is not established.
Conclusion: Possible modest risk in younger women; mortality not increased.
  1. Original statement
  2. Scientific assessment
  3. Scientific evidence in detail
  4. In plain language
  5. Studies on this claim
  6. Regional context
  7. What applies in my country?
  8. References

Original statement

والرحم والمبيضان جزء من شبكة هرمونية تحمي القلب والدماغ والعظام

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Hysterectomy (even with ovaries conserved) harms the heart and metabolism; uterus and ovaries form a hormonal network protecting heart, brain and bone.

Origin

Source status
Archive editors
Attribution
Archive editors (eltayebat.com); not necessarily Elawady's own words
Origin
https://eltayebat.com/rule/unnecessary-organ-removal/
Attribution uncertainty
Editorial summary/narrative and study selection written by the archive operators; the archive states that the cited research documents harm independently of Dr. Diaa's words.
Claimed mechanism

Hormonal network.

Claimed health effect

Cardiovascular and metabolic disease.

Population concerned

Women with benign hysterectomy

Geographic restriction by Elawady

not applicable

Scientific assessment

Potentially true – Some evidence points in favour of the statement, but it is not sufficient for a clear judgement.

Certainty of evidence: low – Further research is likely to change the assessment considerably.

1. What was claimed?

Hysterectomy harms heart and metabolism.

2. What is demonstrably correct?

CVD HR 1.18 in women <50 (A-ORG-10); CAD HR 1.33 and other metabolic conditions even with ovarian conservation, especially <=35 years (A-ORG-11).

3. What is wrong or exaggerated?

Hysterectomy was not associated with increased mortality over >20 years (A-ORG-12, archive-cited but not discussed). No association in women >=50 (A-ORG-10). The 'protective hormonal network' of the uterus is a hypothesis not tested by these studies.

4. What remains unclear?

Causality; mechanisms in ovary-conserving hysterectomy.

5. Which studies support it?

A-ORG-10, A-ORG-11.

6. Which studies contradict it?

A-ORG-12.

7. What applies to Germany and Europe?

Most cited cohorts are Scandinavian (Denmark, Sweden) and directly European; RCTs from the UK and Finland are directly transferable. Guidelines in Europe also emphasize defined indications (not verified here in detail).

8. What is known about Egypt?

No Egypt-specific data on rates or outcomes of tonsillectomy, cholecystectomy, hysterectomy, splenectomy or thyroid surgery were identified in this review.

9. What practical conclusion is appropriate?

Supports considering alternatives for benign conditions in young women.

Assessment details

Rationale for certainty of evidence

Several cohorts show modestly higher CVD after hysterectomy in younger women; an archive-cited cohort found no increase in mortality.

Source quality

Archive-cited Iversen 2005 (null mortality) is not mentioned in the narrative.

Regional transferability

Swedish and UK data.

Individual exceptions

Associations mainly in women operated before 50 (or <=35).

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Overinterpreted – A real finding exists, but the claim draws more from it than the data allow (e.g. association taken as cause, animal data applied to humans, small effect presented as large).

Research question: Does hysterectomy with ovarian conservation increase cardiovascular and metabolic disease?

Research question in detail (PECO)
Population
Women after hysterectomy (ovaries conserved)
Intervention or exposure
Hysterectomy
Comparison
No hysterectomy
Geographic scope
universal biology
Outcomes
  • CVD
  • CHD
  • Stroke
  • Hypertension/metabolic disease
  • Mortality

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

What speaks against the claim?

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

A modest association (about 10-25% relative) between hysterectomy and CVD, especially stroke and in younger women, is consistently found; mortality is not increased; the 'hormonal network' explanation is not established.

Why some studies weigh more

Pooled cohorts plus large matched cohorts.

Is a causal relationship established? Possible, not established Associations could reflect indications (fibroids, endometriosis) and shared risk factors.

Remaining uncertainty

Mechanism; causality.

Justified conclusion

Possible modest risk; not proven harm; mortality not increased.

Why do studies seem to disagree?

Morbidity (CVD, stroke) is increased modestly while mortality is not; these are different endpoints and small relative risks may not translate into detectable mortality differences.

Does this depend on the country?
General biological effects
Universal.
Eating habits
Not relevant to this claim.
Origin of the food
Not applicable.
Contaminants
Not applicable.
National production conditions
Not applicable.
Legal rules
Not applicable.
Actual monitoring data
No Egypt-specific monitoring data identified.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • Absolute excess from incidence rates – 19 per 100,000 PY; about 1 extra event per 5300 woman-years recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
CVD after hysterectomy with ovarian conservation
Starting level
low (observational studies)
Reasons for downgrading
  • risk of bias (confounding by indication)
Reasons for upgrading
  • consistency
Result
low

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026(TITLE:hysterectomy) AND (TITLE:cardiovascular OR TITLE:"coronary" OR TITLE:"heart disease" OR TITLE:hypertension OR TITLE:metabolic) AND (TITLE:"meta-analysis" OR cohort OR "population-based")both directions37

Open questions

Mechanism for CVD after hysterectomy alone.

How deeply was this checked?

5 linked studies: 0 checked in full text (0 of them with a structured risk-of-bias assessment), 5 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: Potentially true (low)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Potentially true (low)
    Unchanged (“Potentially true”, low). New pooled and cohort data confirm a modest CVD association without mortality effect.
    New sources: I-ORG-137 I-ORG-136

In plain language

The archive says removing the uterus harms the heart and metabolism. Some large studies found modestly more heart disease later, especially when the operation was done before age 50. However, another study cited by the archive itself found no increase in deaths over 20 years. The evidence suggests a possible risk, mostly in young women, but not proof.

Studies on this claim

Studies supporting the claim (3)

  • Hysterectomy and heart disease in Sweden

    Ingelsson E et al.. Eur Heart J 2011 · PMID 21186237 · DOI 10.1093/eurheartj/ehq477
    Cohort studycited by the Tayebat archiveabstract checked

    Women operated before 50 had about 18% more cardiovascular disease later.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    CVD

    How was the study done?

    Register

    How many people, animals or samples were studied?

    824,484

    What was actually found?

    Higher CVD <50

    How large was the observed effect?

    HR 1.18

    What do the results mean in everyday life?

    Possible long-term cost

    What are the study's limitations?

    Confounding

    What does it say about Elawady's specific claim?

    Supports association

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Causation

    Scientific details →

  • Hysterectomy with ovaries kept

    Laughlin-Tommaso SK et al.. Menopause 2018 · PMID 29286988 · DOI 10.1097/GME.0000000000001043
    Cohort studycited by the Tayebat archiveabstract checked

    Later heart and metabolic problems were modestly more frequent, especially after surgery at age 35 or younger.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    CV risk

    How was the study done?

    Cohort

    How many people, animals or samples were studied?

    4188

    What was actually found?

    Modest increase

    How large was the observed effect?

    CAD HR 1.33

    What do the results mean in everyday life?

    Consider alternatives when possible

    What are the study's limitations?

    Observational

    What does it say about Elawady's specific claim?

    Supports association

    Do the results apply to Germany and Europe?

    Applicable

    What can explicitly not be concluded from this study?

    Causation

    Scientific details →

  • Hysterectomy before 50 and heart disease in Korea

    Yuk JS et al.. JAMA Netw Open 2023 · PMID 37307002 · DOI 10.1001/jamanetworkopen.2023.17145
    Cohort studyindependent cross-checkabstract checked

    Women who had a hysterectomy in their 40s had about 25% more cardiovascular events, mostly strokes, but the absolute increase was small.

    HR 1.24 for CVD even excluding oophorectomy, in women 40-49.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Study CVD risk after early hysterectomy

    How was the study done?

    Matched national cohort

    How many people, animals or samples were studied?

    55,539 pairs

    What was actually found?

    More CVD, especially stroke

    How large was the observed effect?

    HR 1.25; 115 vs 96 per 100,000 PY

    What do the results mean in everyday life?

    Small extra risk to weigh in elective surgery

    What are the study's limitations?

    Claims data

    What does it say about Elawady's specific claim?

    Supports a modest part of the claim

    Do the results apply to Germany and Europe?

    Moderate

    What can explicitly not be concluded from this study?

    Cannot prove causation

    Scientific details →

Studies contradicting or limiting the claim (1)

  • UK: hysterectomy and death risk

    Iversen L et al.. BMJ 2005 · PMID 15930026 · DOI 10.1136/bmj.38483.669178.8F
    Cohort studycited by the Tayebat archiveabstract checked

    Women who had a hysterectomy did not die earlier over about 20 years.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Mortality

    How was the study done?

    Nested cohort

    How many people, animals or samples were studied?

    7410

    What was actually found?

    No increase

    How large was the observed effect?

    HR 0.94/0.82

    What do the results mean in everyday life?

    No mortality penalty found

    What are the study's limitations?

    Ovary status unclear

    What does it say about Elawady's specific claim?

    Limits claim

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    CVD morbidity

    Scientific details →

Studies with mixed or unclear results (1)

  • Hysterectomy and heart disease: pooled cohort studies

    Chen Y et al.. BJOG 2024 · PMID 38747094 · DOI 10.1111/1471-0528.17843
    Meta-analysisindependent cross-checkabstract checked★ key study

    Hysterectomy was linked to about 10% more cardiovascular disease and stroke, but not to more deaths.

    Modest CVD/stroke association (HR about 1.1) without excess mortality; CHD rise only with oophorectomy.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Pool cohort studies on hysterectomy and heart outcomes

    How was the study done?

    Meta-analysis

    How many people, animals or samples were studied?

    43 studies

    What was actually found?

    CVD HR 1.11; no mortality increase

    How large was the observed effect?

    HR 1.11 (1.09-1.13)

    What do the results mean in everyday life?

    A small possible risk to discuss before elective hysterectomy

    What are the study's limitations?

    Heterogeneity, confounding

    What does it say about Elawady's specific claim?

    Partly supports the claim; contradicts 'harms the heart' as a strong statement

    Do the results apply to Germany and Europe?

    Applicable

    What can explicitly not be concluded from this study?

    Cannot prove causation

    Scientific details →

Regional context

Germany / EU

Most cited cohorts are Scandinavian (Denmark, Sweden) and directly European; RCTs from the UK and Finland are directly transferable. Guidelines in Europe also emphasize defined indications (not verified here in detail).

Egypt

No Egypt-specific data on rates or outcomes of tonsillectomy, cholecystectomy, hysterectomy, splenectomy or thyroid surgery were identified in this review.

What applies in my country?

General scientific assessment

Potentially true Possible modest risk in younger women; mortality not increased.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Hysterectomy and risk of cardiovascular disease: a population-based cohort study.. Ingelsson E et al.. Eur Heart J 2011 · PMID 21186237 · DOI 10.1093/eurheartj/ehq477
  2. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.. Laughlin-Tommaso SK et al.. Menopause 2018 · PMID 29286988 · DOI 10.1097/GME.0000000000001043
  3. Association of Early Hysterectomy With Risk of Cardiovascular Disease in Korean Women.. Yuk JS et al.. JAMA Netw Open 2023 · PMID 37307002 · DOI 10.1001/jamanetworkopen.2023.17145
  4. Long term effects of hysterectomy on mortality: nested cohort study.. Iversen L et al.. BMJ 2005 · PMID 15930026 · DOI 10.1136/bmj.38483.669178.8F
  5. Examining the association of hysterectomy with and without oophorectomy on cardiovascular disease and all-cause, cardiovascular or cancer mortality: A systematic review and meta-analysis.. Chen Y et al.. BJOG 2024 · PMID 38747094 · DOI 10.1111/1471-0528.17843

← Back to overview